Screener
Collegium Pharmaceutical, Inc. COLL Other Non-Current Assets
Other Non-Current Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Intangible assets, net | 1,186,084 | 669,510 |
| Restricted cash | 1,060 | 1,056 |
| Deferred tax assets | 120,774 | 112,539 |
| Other noncurrent assets | 15,237 | 20,193 |
| Goodwill | 190,177 | 145,925 |
| Total assets | $2,135,790 | $1,656,834 |
| Liabilities and shareholders’ equity | ||
| Current liabilities |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s other non-current assets?
- Collegium Pharmaceutical, Inc. (COLL) reported other non-current assets of $15.24M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s other non-current assets changed year-over-year?
- Collegium Pharmaceutical, Inc.'s other non-current assets increased by 296.3% year-over-year, from $3.85M to $15.24M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s other non-current assets has grown at a 177.4% compound annual growth rate (CAGR), from $123K to $20.19M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Collegium Pharmaceutical, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude